このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Shanghai GenTech 将来の成長

Future 基準チェック /56

Shanghai GenTech利益と収益がそれぞれ年間29.2%と25.9%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に18.5% 28.2%なると予測されています。

主要情報

29.2%

収益成長率

28.2%

EPS成長率

Semiconductor 収益成長	39.2%
収益成長率	25.9%
将来の株主資本利益率	18.5%
アナリストカバレッジ	Low
最終更新日	05 Jun 2024

今後の成長に関する最新情報

Recent updates

A Piece Of The Puzzle Missing From Shanghai GenTech Co., Ltd.'s (SHSE:688596) 26% Share Price Climb

Mar 03

業績と収益の成長予測

SHSE:688596 - アナリストの将来予測と過去の財務データ ( )CNY Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	8,665	975	N/A	474	3
12/31/2025	7,148	787	N/A	288	3
12/31/2024	5,707	593	N/A	358	3
3/31/2024	4,013	415	-382	35	N/A
12/31/2023	3,835	401	-245	116	N/A
9/30/2023	3,312	392	-39	251	N/A
6/30/2023	3,106	356	-118	95	N/A
3/31/2023	2,753	259	-500	-275	N/A
12/31/2022	2,705	259	-422	-162	N/A
9/30/2022	2,405	198	-360	-93	N/A
6/30/2022	1,992	167	-379	-69	N/A
3/31/2022	2,027	179	-246	1	N/A
12/31/2021	1,837	168	-207	-20	N/A
9/30/2021	1,669	186	-111	3	N/A
6/30/2021	1,452	152	-64	-11	N/A
3/31/2021	1,170	132	2	41	N/A
12/31/2020	1,109	124	-85	-56	N/A
9/30/2020	1,172	116	-34	-3	N/A
6/30/2020	1,118	94	68	98	N/A
3/31/2020	1,181	90	15	57	N/A
12/31/2019	1,186	83	45	85	N/A
12/31/2018	921	60	90	110	N/A
12/31/2017	707	31	N/A	-43	N/A
6/30/2017	708	28	N/A	-36	N/A
3/31/2017	644	24	N/A	-6	N/A
12/31/2016	580	21	N/A	25	N/A
9/30/2016	540	21	N/A	30	N/A
6/30/2016	501	21	N/A	35	N/A
3/31/2016	506	17	N/A	15	N/A
12/31/2015	512	12	N/A	-4	N/A
12/31/2014	498	16	N/A	47	N/A
12/31/2013	216	-4	N/A	55	N/A

アナリストによる今後の成長予測

収入対貯蓄率: 688596の予測収益成長率 (年間29.2% ) は貯蓄率 ( 2.9% ) を上回っています。

収益対市場: 688596の収益 ( 29.2% ) はCN市場 ( 22.7% ) よりも速いペースで成長すると予測されています。

高成長収益: 688596の収益は今後 3 年間で大幅に増加すると予想されています。

収益対市場: 688596の収益 ( 25.9% ) CN市場 ( 13.9% ) よりも速いペースで成長すると予測されています。

高い収益成長: 688596の収益 ( 25.9% ) 20%よりも速いペースで成長すると予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: 688596の自己資本利益率は、3年後には低くなると予測されています ( 18.5 %)。

Shanghai GenTech 将来の成長

Future 基準チェック /56

主要情報

今後の成長に関する最新情報

Price target decreased by 9.8% to CN¥46.00

Price target decreased by 9.4% to CN¥52.00

Price target decreased by 12% to CN¥50.50

Recent updates

Investor sentiment deteriorates as stock falls 16%

Does Shanghai GenTech (SHSE:688596) Have A Healthy Balance Sheet?

Shanghai GenTech Co., Ltd. (SHSE:688596) announces an Equity Buyback for CNY 50 million worth of its shares.

Shanghai GenTech Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Sentiment Still Eluding Shanghai GenTech Co., Ltd. (SHSE:688596)

Price target decreased by 9.8% to CN¥46.00

Do Shanghai GenTech's (SHSE:688596) Earnings Warrant Your Attention?

New minor risk - Dividend sustainability

Shanghai GenTech's (SHSE:688596) Profits May Not Reveal Underlying Issues

First quarter 2024 earnings released: EPS: CN¥0.09 (vs CN¥0.04 in 1Q 2023)

Shanghai GenTech Co., Ltd., Annual General Meeting, May 24, 2024

Less than half of directors are independent

Shanghai GenTech Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024

Returns On Capital At Shanghai GenTech (SHSE:688596) Have Stalled

A Piece Of The Puzzle Missing From Shanghai GenTech Co., Ltd.'s (SHSE:688596) 26% Share Price Climb

Full year 2023 earnings: EPS exceeds analyst expectations

Shanghai GenTech Co., Ltd. (SHSE:688596) announces an Equity Buyback for CNY 50 million worth of its shares.

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 15%

Third quarter 2023 earnings released: EPS: CN¥0.45 (vs CN¥0.33 in 3Q 2022)

Price target decreased by 9.4% to CN¥52.00

Second quarter 2023 earnings released: EPS: CN¥0.52 (vs CN¥0.19 in 2Q 2022)

First quarter 2023 earnings released: EPS: CN¥0.04 (vs CN¥0.04 in 1Q 2022)

Investor sentiment deteriorates as stock falls 16%

Price target decreased by 12% to CN¥50.50

Investor sentiment improves as stock rises 19%

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥0.33 (vs CN¥0.21 in 3Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Second quarter 2022 earnings released: EPS: CN¥0.19 (vs CN¥0.23 in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Shanghai GenTech Co., Ltd. announced that it expects to receive CNY 300 million in funding

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Shanghai GenTech Co., Ltd. (SHSE:688596) announces an Equity Buyback for CNY 120 million worth of its shares.

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.09 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.23 (vs CN¥0.17 in 2Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.003 (vs CN¥0.07 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.48 (vs CN¥0.45 in FY 2019)

New 90-day low: CN¥15.90

Investor sentiment deteriorated over the past week

New 90-day low: CN¥18.86

New 90-day low: CN¥20.75

Shanghai GenTech Co., Ltd. to Report Q3, 2020 Results on Oct 30, 2020

First half earnings released

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘